Randhawa Simrat's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Sep 3, 2026
- Accession no.
- 0001992260-26-000009
- Filed
- Sep 3, 2026, 4:30 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Randhawa SimratCIK 0001992260 | Officer (EVP, Head of R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | MOption exerciseAcquired | +7,500 | $17.88 | +$134,100 | 11,500 | Direct | |
| Sep 1, 2026 | Common Stock | MOption exerciseAcquired | +6,249 | $21.77 | +$136,040.73 | 17,749 | Direct | |
| Sep 1, 2026 | Common Stock | MOption exerciseAcquired | +9,375 | $22.07 | +$206,906.25 | 27,124 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −2,600 | $105.19 | −$273,494 | 24,524 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −7,215 | $106.25 | −$766,593.75 | 17,309 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −13,309 | $106.74 | −$1,420,602.66 | 4,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 56,776 | Direct | |
| Sep 1, 2026 | Common Stock | MOption exerciseDisposed | −6,249 | $0.00 | $0 | 41,676 | Direct | |
| Sep 1, 2026 | Common Stock | MOption exerciseDisposed | −9,375 | $0.00 | $0 | 87,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.